Dataset from A Randomized, Double-Blind, Double-Dummy Phase 3 Study to Evaluate the Efficacy and Safety of Oral Once-Daily Administration of TAK-438 20 mg Compared to Lansoprazole 30 mg in the Treatment of Subjects With Erosive Esophagitis
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007237
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to demonstrate the efficacy of vonoprazan (TAK-438) versus
lansoprazole in the treatment of erosive esophagitis classified as Los Angeles (LA)
classification grades A to D at Week 8.
创建时间：
2025-10-01
